LSE:VAL - ValiRx PLC - Update on VAL201 sub-license agreement

Drug Development

Our Pipeline Evaluation Pipeline Inaphaea BioLabs Therapeutic Areas Partnering & Useful Links

Investor News & Media

Regulatory News Updates Reports, AGMs & Presentations Share Price Information AIM Rule 26 Analyst Research Webinars

About Us

Board & Management Team Strategy & Vision How we work Working with us Collaborative Pipeline Privacy Policy

ValiRx PLC - Update on VAL201 sub-license agreement

Your question will be sent privately to ValiRx plc. The company may choose to make this question public.

Start the conversation

Ask ValiRx plc a question about this announcement.

Share your feedback

Discover

ValiRx plc

Powered by InvestorHub•Terms and conditions•Privacy policy•Cookie settings•Contact